Search

everythinglearnresearchcommunity

for

Search:↓

Using polymeric micelles to deliver spironolactone topically could improve wound healing in skin affected by glucocorticoids.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

Weekly 5 mg folate is enough to prevent methotrexate toxicity in rheumatoid arthritis patients.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Spironolactone is effective and safe for treating acne in women, especially those over 25 with hormonal imbalances.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Stress worsens Tourette symptoms by increasing allopregnanolone levels.

PUVASOL might effectively treat complete scalp baldness.

Selenium's effectiveness in treating Hashimoto's thyroiditis is inconclusive.

Strontium ranelate is no longer available for treatment.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

Oral Apremilast effectively treats alopecia areata in most patients.

Tedisamil and glibenclamide affect cromakalim and minoxidil sulphate differently in rat aorta.

Corticosteroids effectively treated a 60-year-old man's skin condition.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

The drug combination was safe and showed promise in treating advanced tumors.

A new, efficient method creates sulfinimidate esters from sulfenamides and alcohols without metals.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Applying 2% tofacitinib cream helped some children with severe hair loss grow back hair.